Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Hypoxia01:23

Hypoxia

865
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
865
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

165
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
165
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

2.4K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
2.4K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

159
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
159
Hemoglobin01:24

Hemoglobin

3.2K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
3.2K
Cancer Therapies02:49

Cancer Therapies

7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas
  1. Home
  2. Hypoxystat, Una Forma De Terapia De Hipoxia De Molécula Pequeña Que Aumenta La Afinidad Oxígeno-hemoglobina
  1. Home
  2. Hypoxystat, Una Forma De Terapia De Hipoxia De Molécula Pequeña Que Aumenta La Afinidad Oxígeno-hemoglobina

Video Experimental Relacionado

Induction and Testing of Hypoxia in Cell Culture
07:01

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

84.6K

HypoxyStat, una forma de terapia de hipoxia de molécula pequeña que aumenta la afinidad oxígeno-hemoglobina

Skyler Y Blume1, Ankur Garg1, Yolanda Martí-Mateos1

  • 1Gladstone Institutes, San Francisco, CA 94158, USA; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94158, USA.

Cell
|February 18, 2025

Ver abstracta en PubMed

Resumen
Este resumen es generado por máquina.

Una nueva molécula pequeña, HypoxyStat, imita la hipoxia terapéutica para las enfermedades mitocondriales. La administración oral prolongó la vida útil y revirtió los síntomas de la enfermedad en los ratones con knockout de Ndufs4, ofreciendo un tratamiento clínico potencial.

Palabras clave:
Síndrome de Leighy la hemoglobinahiperoxiahipoxiaEnfermedad mitocondrialoxígenoglóbulos rojostratamiento

Más Videos Relacionados

Supramaximal Intensity Hypoxic Exercise and Vascular Function Assessment in Mice
10:00

Supramaximal Intensity Hypoxic Exercise and Vascular Function Assessment in Mice

Published on: March 15, 2019

8.3K
Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
09:17

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

17.4K

Videos de Experimentos Relacionados

Induction and Testing of Hypoxia in Cell Culture
07:01

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

84.6K
Supramaximal Intensity Hypoxic Exercise and Vascular Function Assessment in Mice
10:00

Supramaximal Intensity Hypoxic Exercise and Vascular Function Assessment in Mice

Published on: March 15, 2019

8.3K
Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
09:17

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

17.4K

Área de la Ciencia:

  • Biología mitocondrial
  • La neurociencia
  • Farmacología

Sus antecedentes:

  • La hipoxia inhalada crónica muestra potencial terapéutico en modelos animales del síndrome de Leigh mitocondrial.
  • Las terapias basadas en gases existentes se enfrentan a desafíos para la traducción clínica.
  • Las enfermedades mitocondriales, incluido el síndrome de Leigh, representan importantes necesidades médicas no cubiertas.

Objetivo del estudio:

  • Evaluar una pequeña molécula (HypoxyStat) como una alternativa clínicamente manejable a la terapia de hipoxia inhalada.
  • Determinar si la administración oral de HypoxyStat puede mitigar la progresión de la enfermedad en el modelo de ratón nocaut Ndufs4 del síndrome de Leigh mitocondrial.
  • Evaluar la eficacia de HypoxyStat en la prevención y la reversión de los fenotipos de la enfermedad.

Principales métodos:

  • Administración diaria de HypoxyStat, una pequeña molécula que aumenta la afinidad de unión de la hemoglobina con el oxígeno, a través de dosis orales a ratones con knockout de Ndufs4.
  • Evaluación de la esperanza de vida, los cambios de comportamiento, el peso corporal, la temperatura corporal y la neuropatología en ratones tratados y de control.
  • Inducción de la hipoxia sistémica en ratones que respiran aire normoxico mediante el tratamiento con HypoxyStat.

Principales resultados:

  • La administración diaria de HypoxyStat prolongó significativamente la vida útil de los ratones con knockout de Ndufs4.
  • El tratamiento rescató aspectos clave de la enfermedad, incluida la mejora del comportamiento, el peso corporal y la temperatura corporal.
  • HypoxyStat demostró eficacia incluso cuando se administró en etapas avanzadas de la enfermedad, revirtiendo los síntomas.
  • La molécula indujo hipoxia sistémica en ratones que respiraban aire normal.

Conclusiones:

  • HypoxyStat representa un agente terapéutico oral prometedor para las enfermedades mitocondriales.
  • Esta pequeña molécula imita efectivamente los beneficios de la terapia de hipoxia inhalada, superando los desafíos del parto.
  • HypoxyStat ofrece un enfoque clínicamente manejable para el tratamiento del síndrome de Leigh mitocondrial y potencialmente otras afecciones relacionadas.